PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018
The Systems for Improved Access to Pharmaceuticals and Services (SIAPS) project is a new project which will continue the activities initiated with Strengthening Pharmaceuticals Systems (SPS). The SIAPS's goal is to assure the availability of quality pharmaceutical products and effective pharmaceutical services to achieve desired health outcomes, by promoting and utilizing a systems strengthening approach consistent with the Global Health Initiative (GHI) that will result in improved and sustainable health impact. The SIAPS project works at the central level to support the National Drug Regulatory Authority (NDRA) and Direcção Nacional de Assistência Médica/Departamento Farmácia Hospitalar (DNAM/DFH) on drug registration, pharmaceutical policy, formularies of Medicines, Standard Treatment Guidelines (STG), pharmacovigilance, HR strategies and pre-service curriculum, medicine selection, and support to the Technical Committee of Therapeutics and Pharmacy (CTTF). The project will support treatment scale up by strengthening ART and PMTCT pharmaceutical dispensing services. The primary focus of the SIAPS project will be on establishing sustainable systems for government and it is expected that the partner will work closely with the Ministry of Health to build ownership in strengthening the NDRA and DNAM/DFH to strengthen pharmacy services.The SIAPS Program Performance Monitoring Plan (PMP) will include a clearly defined Results Framework with indicators, baselines, and targets for output and impact level monitoring. This is a newly awarded central level mechanism and there no costing data available at the moment. USG plan to include central level mechanisms in the next expenditure analysis and costing exercises. No purchased/leased vehicles under this mechanism.
Systems for Improved Access to Pharmaceuticals and Services (SIAPS) will assist Pharmaceutical Department in developing and updating national medicines policies, standard treatment guidelines and essential medicines lists, coordinate and collaborate with WHO, International Society of Pharmacovigilance (ISoP), GFATM and other global initiatives to advance the pharmacovigilance and patient safety agenda. Assist national drug regulatory authorities; strengthen drug registration systems, including developing expedited review procedures. Provide global technical leadership on good governance in medicines. Work with DNAM to support the new Department on Pharmaceutical Services (Departamento de Farmácia Hospitalar - DFH) to implement rational drug use, management of dispensing pharmacies in the hospitals and health centers, including implementation of prescriptions protocols and guarantee that prescription levels are adhered to or modified as necessary for programs objectives, work with DFH to implement and expand use of Information, Education and Communication/Behavior Change Communication (IEC/BCC) messages and strategies in the public sector for providers and patients on responsible self-medication and adherence to recommended treatment regimens. Previously funded for pharmacy curriculum, COP 12 would be to support overall HR strategy for Pharmacy Sector. SIAPS will work with relevant stockholders, HR, Pharmaceutical Department(PD), Central de Medicamentos e Artigos Médicos (CMAM) and Institutos de Ciências de Saúde (ICS) to develop pre-service and in-service pharmaceutical management training materials for health workers at all levels of the health system and help facilitate training; Support training of faculties of medicine, nursing and pharmacy in Antimicrobial Resistance (AMR) containment, appropriate medicines use, and therapeutic outcomes monitoring; Promote the professionalization of supply chain managers and service providers. Work with professional associations, educational institutions, and medical and pharmacy faculty and schools to develop and implement continuing education programs on pharmaceutical management.SIAPS will support the Ministry for planning, coordination, and financing commodities procurement and monitoring needs, institutionalization of quantification processes, and development of framework, roles and responsibilities. Support MoH to strengthening financing mechanisms to improve access to medicines. Work with MoH (CMAM and PD) to identify viable cost-sharing and cost-recovery mechanisms for medicines. SIAPS will work with DNAM, MoH and partners to assess requirements and develop Pharmaceutical Management Information System for Service Deliver Points - dispensing pharmacies - for collecting and sharing data on supply chain management, prescribing, dispensing, and adherence and patient outcomes. SIAPS will work with MoH to explore sustainable financing strategies for health commodities. SIAPS will also work with MoH/CMAM to conduct financial analyses to project future budgetary requirements for medicines needs resulting from on-going and expanding treatment programs; assess the impact of the introduction of new health technologies; conduct options analysis to enhance system performance and efficiencies, including contracting out pharmaceutical management operations; identify opportunities to leverage disease-specific funding sources to support pharmaceutical system strengthening.
